Lead researcher Lottie Brown from the University of Manchester today publishes the first estimation of global fungal keratitis figures in Lancet Infectious Diseases. Infection of the transparent ...

One notable study compared PACK-CXL with standard antimicrobial therapy in a randomized trial involving patients with bacterial, fungal, or mixed infectious keratitis. The results indicated that ...

in patients with severe fungal, bacterial or acanthamoeba keratitis. There was no significant difference between the two groups in terms of eradication of infection (84 vs 86% (p = 0.74).

Fungal contamination in eye drops can lead to fungal keratitis, a severe infection of the cornea that can cause vision loss or blindness due to scarring and corneal damage. In the most extreme ...

According to the company’s statement, the collaboration aims to leverage the combined expertise and resources of both organizations to develop a safe and efficacious drug for fungal keratitis.